(Q38756737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Marcela Herrera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Magnus Söderberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Barbara Valastro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Johan Mölne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Beatriz Santamaria

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Angela M Valverde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Silvia Guionaud

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Stephanie Heasman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Alison Bigley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Lutz Jermutus

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Cristina Rondinone

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Matthew Coghlan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

David Baker

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Carol Moreno Quinn

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

20 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

F748-F759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Macrophages in kidney injury, inflammation, and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

21 January 2018

Diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

B7-1 expression regulates the hypoxia-driven cytoskeleton rearrangement in glomerular podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Chemokines in renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Overview of the cellular and molecular basis of kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Role of podocyte B7-1 in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Mechanisms of diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Leukocyte recruitment and vascular injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Monocyte subpopulations and cardiovascular risk in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Distinct macrophage phenotypes contribute to kidney injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Inflammatory processes in renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Aberrant recruitment and activation of T cells in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Targeting chemokines in proteinuria-induced renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Clinical practice. Nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Mechanisms and treatment of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Diabetic nephropathy: important pathophysiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Macrophages and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Update on the use of abatacept for the treatment of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Increased accumulation of CD16+ monocytes at local sites of inflammation in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Macrophages in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Role of T cells in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

Abatacept in B7-1-positive proteinuric kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00179.2016

10.1152/AJPRENAL.00179.2016

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27440778%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference